(Q38542687)

4 September 2017

1 reference

title

Targeting Opioid-Induced Hyperalgesia in Clinical Treatment: Neurobiological Considerations (English)

1 reference

Opioid-induced hyperalgesia

4 September 2017

1 reference

1

0 references

author name string

Ellen Edens

series ordinal

2

1 reference

PubMed ID

26142224

4 September 2017

Ismene L Petrakis

series ordinal

3

1 reference

PubMed ID

26142224

4 September 2017

Mehmet Sofuoglu

series ordinal

4

1 reference

4 September 2017

4 July 2015

1 reference

4 September 2017

1 reference

4 September 2017

29

1 reference

4 September 2017

6

1 reference

4 September 2017

465-486

1 reference

https://scigraph.springernature.com/pub.10.1007/s40263-015-0255-x

4 September 2017

0 references

cites work

The economic costs of pain in the United States

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

National Institutes of Health Pathways to Prevention Workshop: the role of opioids in the treatment of chronic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Prevalence of chronic pain, impact on daily life, and treatment practices in India

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Chronic pain, opioid prescriptions, and mortality in Denmark: A population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Prevalence, causes, severity, impact, and management of chronic pain in Australian general practice patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The prevalence of chronic pain in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid overuse pain syndrome (OOPS): the story of opioids, prometheus unbound

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Prescription drug overdoses: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid therapy for chronic pain in the United States: promises and perils

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Induction of pain facilitation by sustained opioid exposure: relationship to opioid antinociceptive tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid-induced hyperalgesia: clinically relevant or extraneous research phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid-induced hyperalgesia in humans: molecular mechanisms and clinical considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Gabapentin improves cold-pressor pain responses in methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Difference of the naltrexone's effects in social drinkers by spicy food preference.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid-induced hyperalgesia (OIH): a real clinical problem or just an experimental phenomenon?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid-induced hyperalgesia: is it clinically relevant for the treatment of pain patients?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Morphine induced allodynia in a child with brain tumour

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid-induced hyperalgesia and burn pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Clinical interpretation of opioid tolerance versus opioid-induced hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Mechanisms of opioid-induced pain and antinociceptive tolerance: descending facilitation and spinal dynorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid-induced hyperalgesia: abnormal or normal pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Antinociceptive and nociceptive actions of opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Antagonists of toll like receptor 4 maybe a new strategy to counteract opioid-induced hyperalgesia and opioid tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Neurocircuitry of illness-induced hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The "toll" of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid tolerance and hyperalgesia in chronic pain patients after one month of oral morphine therapy: a preliminary prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Morphine hyperalgesia in mice is unrelated to opioid activity, analgesia, or tolerance: evidence for multiple diverse hyperalgesic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Hyperalgesia in heroin dependent patients and the effects of opioid substitution therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Acute and chronic fentanyl administration causes hyperalgesia independently of opioid receptor activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

C-Fos activation in the periaqueductal gray following acute morphine-3β-D-glucuronide or morphine administration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Modulation of remifentanil-induced postinfusion hyperalgesia by the β-blocker propranolol in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Effects of COX inhibition on experimental pain and hyperalgesia during and after remifentanil infusion in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The analgesic efficiency of combined pregabalin and ketamine for total hip arthroplasty: a randomised, double-blind, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Disappearance of morphine-induced hyperalgesia after discontinuing or substituting morphine with other opioid agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Does intrathecal fentanyl produce acute cross-tolerance to i.v. morphine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Intraoperative high dose fentanyl induces postoperative fentanyl tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Acute opioid tolerance: intraoperative remifentanil increases postoperative pain and morphine requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

A comparison of ketamine and paracetamol for preventing remifentanil induced hyperalgesia in patients undergoing total abdominal hysterectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Effect of oral pregabalin on opioid-induced hyperalgesia in patients undergoing laparo-endoscopic single-site urologic surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The impact of opioid-induced hyperalgesia for postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Pain intolerance in opioid-maintained former opiate addicts: effect of long-acting maintenance agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Methadone maintenance patients are cross-tolerant to the antinociceptive effects of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioids and abnormal pain perception: New evidence from a study of chronic opioid addicts and healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid-induced hyperalgesia: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Modulation of remifentanil-induced analgesia, hyperalgesia, and tolerance by small-dose ketamine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Differential modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by S-ketamine and clonidine in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Withdrawal hyperalgesia after acute opioid physical dependence in nonaddicted humans: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Hyperalgesia induced by low-dose opioid treatment before orthopaedic surgery: An observational case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid use prior to total hip arthroplasty leads to worse clinical outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

High opioid dosage rapid detoxification of cancer patient in palliative care with the Raffaeli model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Pain management with intrathecal clonidine in a colon cancer patient with opioid hyperalgesia: case presentation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Perioperative dilemma: challenges of the management of a patient on mega doses of morphine and methadone.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid tolerance development: a pharmacokinetic/pharmacodynamic perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Nociception increases during opioid infusion in opioid receptor triple knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Morphine hyperalgesia gated through microglia-mediated disruption of neuronal Cl⁻ homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Potentiated startle and hyperalgesia during withdrawal from acute morphine: effects of multiple opiate exposures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Effects of recurrent withdrawal on spinal GABA release during chronic morphine infusion in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Ketorolac prevents recurrent withdrawal induced hyperalgesia but does not inhibit tolerance to spinal morphine in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Short-term infusion of the mu-opioid agonist remifentanil in humans causes hyperalgesia during withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Is development of hyperalgesia, allodynia and myoclonus related to morphine metabolism during long-term administration? Six case histories

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Cold-pressor pain tolerance in opiate and cocaine abusers: correlates of drug type and use status

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid pseudoaddiction--an iatrogenic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Intrathecal high-dose morphine induces spinally-mediated behavioral responses through NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Central sensitization and LTP: do pain and memory share similar mechanisms?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Central sensitization: implications for the diagnosis and treatment of pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Role of NK-1 neurotransmission in opioid-induced hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Molecular cloning, structural characterization and functional expression of the human substance P receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Spinally administered dynorphin A produces long-lasting allodynia: involvement of NMDA but not opioid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Neuroimmune activation and neuroinflammation in chronic pain and opioid tolerance/hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Implications of central immune signaling caused by drugs of abuse: mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Proinflammatory cytokines oppose opioid-induced acute and chronic analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Discovery of a novel site of opioid action at the innate immune pattern-recognition receptor TLR4 and its role in addiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Evidence that opioids may have toll-like receptor 4 and MD-2 effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Immune activation: the role of pro-inflammatory cytokines in inflammation, illness responses and pathological pain states

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Direct evidence of astrocytic modulation in the development of rewarding effects induced by drugs of abuse

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Morphine enhances microglial migration through modulation of P2X4 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Morphine-induced chemotaxis and brain-derived neurotrophic factor expression in microglia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid activation of toll-like receptor 4 contributes to drug reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The effect of morphine on glial cells as a potential therapeutic target for pharmacological development of analgesic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Morphine activates neuroinflammation in a manner parallel to endotoxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Effect of repeated administrations of heroin, naltrexone, methadone, and alcohol on morphine glucuronidation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Inhibition of Morphine Tolerance and Dependence by the NMDA Receptor Antagonist MK-801

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Effects of noncompetitive N-methyl-D-aspartate receptor antagonists on opiate tolerance and physical dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

'Balanced analgesia' in the perioperative period: is there a place for ketamine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

N-methyl-D-aspartate-induced excitation and sensitization of normal and inflamed nociceptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Mechanisms underlying NMDA receptor synaptic/extrasynaptic distribution and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Supplementing desflurane-remifentanil anesthesia with small-dose ketamine reduces perioperative opioid analgesic requirements

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Chronic opioid potentiates presynaptic but impairs postsynaptic N-methyl-D-aspartic acid receptor activity in spinal cords: implications for opioid hyperalgesia and tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid- and GABA(A)-receptors are co-expressed by neurons in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Norman Cousins Lecture. Glia as the "bad guys": implications for improving clinical pain control and the clinical utility of opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Opioid inhibition of GABA release from presynaptic terminals of rat hippocampal interneurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

How opioids inhibit GABA-mediated neurotransmission.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Potential role of allopregnanolone for a safe and effective therapy of neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Revisiting the roles of progesterone and allopregnanolone in the nervous system: resurgence of the progesterone receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Allopregnanolone: state of the art.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Mice lacking multidrug resistance protein 3 show altered morphine pharmacokinetics and morphine-6-glucuronide antinociception

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Morphine-6beta-glucuronide rapidly increases pain sensitivity independently of opioid receptor activity in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Relationships between plasma concentrations of morphine, morphine-3-glucuronide, morphine-6-glucuronide, and intravenous morphine titration outcomes in the postoperative period

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

CSF and plasma concentrations of morphine and morphine glucuronides in cancer patients receiving epidural morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Clinical pharmacokinetics of morphine and its metabolites during morphine dose titration for chronic cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

A murine model of opioid-induced hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Establishing "best practices" for opioid rotation: conclusions of an expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Morphine and hydromorphone-induced hyperalgesia in a hospice patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Morphine hyperalgesia: a case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Hyperalgesia and myoclonus with intrathecal infusion of high-dose morphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Improved opioid analgesic effect following opioid dose reduction

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Sex-specific mediation of opioid-induced hyperalgesia by the melanocortin-1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Sex differences in hyperalgesia during morphine infusion: effect of gonadectomy and estrogen treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Progesterone rapidly recruits female-typical opioid-induced hyperalgesic mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Modulation of remifentanil-induced analgesia and postinfusion hyperalgesia by parecoxib in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The interaction of ketamine with the opiate receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Ketamine in pain management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The role of ketamine in preventing fentanyl-induced hyperalgesia and subsequent acute morphine tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Preemptive effect of fentanyl and ketamine on postoperative pain and wound hyperalgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Intraoperative epidural analgesia combined with ketamine provides effective preventive analgesia in patients undergoing major digestive surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Postoperative pain: the effect of low-dose ketamine in addition to general anesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The benefits of intraoperative small-dose ketamine on postoperative pain after anterior cruciate ligament repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Intraoperative small-dose ketamine enhances analgesia after outpatient knee arthroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Postoperative ketamine administration decreases morphine consumption in major abdominal surgery: a prospective, randomized, double-blind, controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Effects of norketamine enantiomers in rodent models of persistent pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Population pharmacokinetics of S-ketamine and norketamine in healthy volunteers after intravenous and oral dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Ketamine for pain in adults and children with cancer: a systematic review and synthesis of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The role of dextromethorphan in pain control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Pharmacological treatment of opioid-induced hyperalgesia: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

N-methyl-D-aspartate (NMDA) receptors, mu and kappa opioid tolerance, and perspectives on new analgesic drug development

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Dextromethorphan attenuated inflammation and combined opioid use in humans undergoing methadone maintenance treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Dextromethorphan and quinidine combination for heroin detoxification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

A double-blind, placebo-controlled trial of dextromethorphan combined with clonidine in the treatment of heroin withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Combined pre-incisional oral dextromethorphan and epidural lidocaine for postoperative pain reduction and morphine sparing: a randomised double-blind study on day-surgery patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Dextromethorphan for the reduction of immediate and late postoperative pain and morphine consumption in orthopedic oncology patients: a randomized, placebo-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Dextromethorphan and pain after total abdominal hysterectomy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Lack of effect of chronic dextromethorphan on experimental pain tolerance in methadone-maintained patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Characterization of N-methyl-D-aspartate receptor subunits responsible for postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Pregabalin: a novel gamma-aminobutyric acid analogue in the treatment of neuropathic pain, partial-onset seizures, and anxiety disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Gabapentin: pharmacology and its use in pain management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The beta2 adrenergic receptor regulates morphine tolerance and physical dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Prostaglandins and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Brief, low frequency stimulation of rat peripheral C-fibres evokes prolonged microglial-induced central sensitization in adults but not in neonates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Minocycline suppresses morphine-induced respiratory depression, suppresses morphine-induced reward, and enhances systemic morphine-induced analgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Systemic administration of propentofylline, ibudilast, and (+)-naltrexone each reverses mechanical allodynia in a novel rat model of central neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Ibudilast: a review of its pharmacology, efficacy and safety in respiratory and neurological disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Ibudilast in healthy volunteers: safety, tolerability and pharmacokinetics with single and multiple doses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Minocycline and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The effects of pregabalin and the glial attenuator minocycline on the response to intradermal capsaicin in patients with unilateral sciatica

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Minocycline enhances the effectiveness of nociceptin/orphanin FQ during neuropathic pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Molecular characterization of a peripheral receptor for cannabinoids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Are oral cannabinoids safe and effective in refractory neuropathic pain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Dose-dependent effects of smoked cannabis on capsaicin-induced pain and hyperalgesia in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Lack of analgesic efficacy of oral delta-9-tetrahydrocannabinol in postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Effects of nabilone, a synthetic cannabinoid, on postoperative pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Lack of analgesia by oral standardized cannabis extract on acute inflammatory pain and hyperalgesia in volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Efficacy of dronabinol as an adjuvant treatment for chronic pain patients on opioid therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Initial experiences with medicinal extracts of cannabis for chronic pain: results from 34 'N of 1' studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? Randomised double blind placebo controlled crossover trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

A preliminary controlled study to determine whether whole-plant cannabis extracts can improve intractable neurogenic symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Cannabis in painful HIV-associated sensory neuropathy: a randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Analgesic effect of the synthetic cannabinoid CT-3 on chronic neuropathic pain: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

A multicenter dose-escalation study of the analgesic and adverse effects of an oral cannabis extract (Cannador) for postoperative pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Nabilone for the treatment of pain in fibromyalgia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Smoked medicinal cannabis for neuropathic pain in HIV: a randomized, crossover clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus avulsion: results of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The pharmacokinetics, efficacy, safety, and ease of use of a novel portable metered-dose cannabis inhaler in patients with chronic neuropathic pain: a phase 1a study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Dronabinol and chronic pain: importance of mechanistic considerations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The analgesic effect of oral delta-9-tetrahydrocannabinol (THC), morphine, and a THC-morphine combination in healthy subjects under experimental pain conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Delta(9)-tetrahydrocannabinol and the opioid receptor agonist piritramide do not act synergistically in postoperative pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Neurosteroids: endogenous bimodal modulators of the GABAA receptor. Mechanism of action and physiological significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Neurosteroids: endogenous regulators of the GABA(A) receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

GABAA and glycine receptor-mediated transmission in rat lamina II neurones: relevance to the analgesic actions of neuroactive steroids.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Analgesic strategies aimed at stimulating the endogenous production of allopregnanolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

New evidence that both T-type calcium channels and GABAA channels are responsible for the potent peripheral analgesic effects of 5alpha-reduced neuroactive steroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Progesterone metabolites, effective at the GABAA receptor complex, attenuate pain sensitivity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Testosterone enhances aggression of wild-type mice but not those deficient in type I 5alpha-reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Progesterone enhances motor, anxiolytic, analgesic, and antidepressive behavior of wild-type mice, but not those deficient in type 1 5 alpha-reductase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Increased progesterone production during the luteal phase of menstruation may decrease anesthetic requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

The relationship between serum progesterone concentration and anesthetic and analgesic requirements: a prospective observational study of parturients undergoing cesarean delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Risks, management, and monitoring of combination opioid, benzodiazepines, and/or alcohol use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Heritability of nociception I: responses of 11 inbred mouse strains on 12 measures of nociception

21 January 2018

2 references

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

21 January 2018

12 December 2020

Genetic variants of the P-glycoprotein gene Abcb1b modulate opioid-induced hyperalgesia, tolerance and dependence

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

A genetic analysis of opioid-induced hyperalgesia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Epigenetic regulation of opioid-induced hyperalgesia, dependence, and tolerance in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Chronic opioid use is associated with increased DNA methylation correlating with increased clinical pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Hyperalgesic responses in methadone maintenance patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40263-015-0255-X

Tramadol induced paradoxical hyperalgesia

21 January 2018

1 reference

12 December 2020

Morphine induces hyperalgesia without involvement of μ-opioid receptor or morphine-3-glucuronide

1 reference

12 December 2020

Opioid-induced glial activation: mechanisms of activation and implications for opioid analgesia, dependence, and reward.

1 reference

12 December 2020

Opioid-induced hyperalgesia method is a clinically relevant issue

1 reference

12 December 2020

Vital signs: variation among States in prescribing of opioid pain relievers and benzodiazepines - United States, 2012.

1 reference

12 December 2020

The treatment of heroin addicts with dextromethorphan: a double-blind comparison of dextromethorphan with chlorpromazine

1 reference

12 December 2020

Single intrathecal injections of dynorphin A or des-Tyr-dynorphins produce long-lasting allodynia in rats: blockade by MK-801 but not naloxone

1 reference

12 December 2020

Cytokine involvement in dynorphin-induced allodynia

1 reference

12 December 2020

Patterns of illicit drug use and opioid abuse in patients with chronic pain at initial evaluation: a prospective, observational study.

1 reference

12 December 2020

Preoperative dextromethorphan reduces intraoperative but not postoperative morphine requirements after laparotomy.

1 reference

12 December 2020

Sustained morphine exposure induces a spinal dynorphin-dependent enhancement of excitatory transmitter release from primary afferent fibers.

1 reference

12 December 2020

Tonic descending facilitation from the rostral ventromedial medulla mediates opioid-induced abnormal pain and antinociceptive tolerance.

1 reference

12 December 2020

Intrathecal high dose morphine produces hyperalgesia in the rat

1 reference

12 December 2020

The ED50 and ED95 of ketamine for prevention of postoperative hyperalgesia after remifentanil-based anaesthesia in patients undergoing laparoscopic cholecystectomy.

1 reference

12 December 2020

Opioid-induced hyperalgesia after rapid titration with intravenous morphine: Switching and re-titration to intravenous methadone

1 reference

12 December 2020

Analgesic and antihyperalgesic effects of nabilone on experimental heat pain

1 reference

12 December 2020

Noxious heating of the skin releases immunoreactive substance P in the substantia gelatinosa of the cat: a study with antibody microprobes

1 reference

12 December 2020

Opiate tolerance to daily heroin administration: an apparent phenomenon associated with enhanced pain sensitivity

1 reference

12 December 2020

Opiate withdrawal with dextromethorphan

1 reference

12 December 2020

Heritability of nociception II. 'Types' of nociception revealed by genetic correlation analysis

1 reference

12 December 2020

Opioid-induced hyperalgesia in community-dwelling adults with chronic pain

1 reference

12 December 2020

Direct costs of opioid abuse in an insured population in the United States

1 reference

12 December 2020

Hyperalgesia during opioid abstinence: mediation by glutamate and substance p.

1 reference

12 December 2020

Cell type and conduction velocity of rat primary sensory neurons with substance P-like immunoreactivity

1 reference

12 December 2020

A pilot study of dextromethorphan in naloxone-precipitated opiate withdrawal

1 reference

12 December 2020

Opioid complications and side effects.

1 reference

12 December 2020

Transmission of chronic nociception by spinal neurons expressing the substance P receptor

1 reference

12 December 2020

Comparison of pain models to detect opioid-induced hyperalgesia

1 reference

12 December 2020

Effects of Dextromethorphan on reducing methadone dosage in opium addicts undergoing methadone maintenance therapy: A double blind randomized clinical trial.

1 reference

12 December 2020

A comprehensive review of opioid-induced hyperalgesia.

1 reference

12 December 2020

Ketamine potentiates analgesic effect of morphine in postoperative epidural pain control.

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of subcutaneous naltrexone pellets in the rat

1 reference

12 December 2020

Clinically available NMDA receptor antagonists memantine and dextromethorphan reverse existing tolerance to the antinociceptive effects of morphine in mice

1 reference

12 December 2020

The antinociceptive effect of the asthma drug ibudilast in rat models of peripheral and central neuropathic pain

1 reference

12 December 2020

Intravenous infusion of the NMDA antagonist, ketamine, in chronic posttraumatic pain with allodynia: a double-blind comparison to alfentanil and placebo

1 reference

12 December 2020

Analgesic effects of the progesterone metabolite, 3 alpha-hydroxy-5 alpha-pregnan-20-one, and possible modes of action in mice

1 reference

12 December 2020

Preemptive ketamine decreases postoperative narcotic requirements in patients undergoing abdominal surgery.

1 reference

12 December 2020

Ketamine--its pharmacology and therapeutic uses.

1 reference

12 December 2020

The role of opioid prescription in incident opioid abuse and dependence among individuals with chronic noncancer pain: the role of opioid prescription

1 reference

12 December 2020

Using methadone to treat opioid-induced hyperalgesia and refractory pain

1 reference

12 December 2020

Relationship of mu- and delta-opioid receptors to GABAergic neurons in the central nervous system, including antinociceptive brainstem circuits

1 reference

12 December 2020

Opioid-induced hyperalgesia: a review of epidemiology, mechanisms and management

1 reference

12 December 2020

The effects of pain on opioid tolerance: how do we resolve the controversy?

1 reference

12 December 2020

ADDITIONAL STEROIDS WITH LUTEOID ACTIVITY

1 reference

12 December 2020

A negative correlation between hyperalgesia and analgesia in patients with chronic radicular pain: is hydromorphone therapy a double-edged sword?

1 reference

12 December 2020

Activation of protein kinase C in the spinal cord produces mechanical hyperalgesia by activating glutamate receptors, but does not mediate chronic muscle-induced hyperalgesia

1 reference

12 December 2020

American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.

1 reference

12 December 2020

Long-lasting increased pain sensitivity in rat following exposure to heroin for the first time

1 reference

12 December 2020

Dynorphin promotes abnormal pain and spinal opioid antinociceptive tolerance.

1 reference

12 December 2020

Preoperative oral dextromethorphan does not reduce pain or analgesic consumption in children after adenotonsillectomy.

1 reference

12 December 2020

High dose of spinal morphine produce a nonopiate receptor-mediated hyperesthesia: clinical and theoretic implications.

1 reference

12 December 2020

An examination of the central sites of action of cannabinoid-induced antinociception in the rat

1 reference

12 December 2020

Role of testosterone on pain threshold in rats

1 reference

12 December 2020

Paroxysmal opioid-induced pain and hyperalgesia.

1 reference

12 December 2020

The therapeutic effect of adding dextromethorphan to clonidine for reducing symptoms of opioid withdrawal: a randomized clinical trial

1 reference

12 December 2020

Chronic morphine induces downregulation of spinal glutamate transporters: implications in morphine tolerance and abnormal pain sensitivity.

1 reference

12 December 2020

Neuropathic pain: the paradox of dynorphin

1 reference

12 December 2020

Pronociceptive actions of dynorphin maintain chronic neuropathic pain

1 reference

12 December 2020

10.1007/S40263-015-0255-X

Identifiers

DOI

1 reference

4 September 2017

1 reference

PubMed ID

26142224